![Todd Wider](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Todd Wider
Directeur/Membre du Conseil chez
ASP ISOTOPES INC.
Fortune : 5 M $ au 31/05/2026
Profil
Todd Wider is currently Director at Varian Biopharmaceuticals, Inc., Director at Varian Biopharma, Inc., Independent Non-Executive Director at ASP Isotopes, Inc. since 2021, Independent Director at Genenta Science SpA since 2024, and Principal at Wider Film Projects.
Former roles include Executive Chairman & Chief Medical Officer at Emendo Biotherapeutics, Inc. from 2018 to 2024, Independent Director at Abeona Therapeutics, Inc., Independent Director at ARYA Sciences Acquisition Corp.
from 2018 to 2020, Independent Director at ARYA Sciences Acquisition Corp.
II in 2020, Independent Director at ARYA Sciences Acquisition Corp.
IV, Independent Director at ARYA Sciences Acquisition Corp.
V, Independent Director at ARYA Sciences Acquisition Corp.
III from 2020 to 2021, Director at Lyfebulb LLC, and Principal at Memorial Sloan Kettering Cancer Center.
Education includes undergraduate studies at Princeton University and a doctorate from Columbia University College of Physicians & Surgeons.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ASP ISOTOPES, INC. 0,53 % | 30/06/2026 | 672 247 ( 0,53 % ) | 5 M $ | 31/05/2026 |
Postes actifs de Todd Wider
| Sociétés | Poste | Début |
|---|---|---|
| ASP ISOTOPES INC. | Directeur/Membre du Conseil | 01/10/2021 |
| GENENTA SCIENCE S.P.A. | Directeur/Membre du Conseil | 02/05/2024 |
Wider Film Projects | Corporate Officer/Principal | - |
Varian Biopharmaceuticals, Inc.
 Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Directeur/Membre du Conseil | - |
Anciens postes connus de Todd Wider
| Sociétés | Poste | Fin |
|---|---|---|
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Président | 01/03/2024 |
| ARYA SCIENCES ACQUISITION III A | Directeur/Membre du Conseil | 01/06/2021 |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Directeur/Membre du Conseil | 01/11/2020 |
| ARYA SCIENCES ACQUISITION CORP. | Directeur/Membre du Conseil | 01/03/2020 |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates cancer hospital | Corporate Officer/Principal | - |
Formation de Todd Wider
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates cancer hospital | Health Services |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genenta Science SpA
 Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
ARYA Sciences Acquisition Corp.
 ARYA Sciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Health Technology |
ARYA Sciences Acquisition Corp. II
 ARYA Sciences Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Lyfebulb LLC
 Lyfebulb LLC Internet Software/ServicesTechnology Services Operates as an online digital platform for people living with chronic illnesses | Technology Services |
Wider Film Projects | |
ARYA Sciences Acquisition Corp. III
 ARYA Sciences Acquisition Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
ARYA Sciences Acquisition Corp. IV
 ARYA Sciences Acquisition Corp. IV Financial ConglomeratesFinance Operates as a blank check company | Finance |
Varian Biopharmaceuticals, Inc.
Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Health Technology |
ARYA Sciences Acquisition Corp. V
 ARYA Sciences Acquisition Corp. V Financial ConglomeratesFinance Operates as a blank check company | Finance |
ASP Isotopes, Inc.
 ASP Isotopes, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pre-commercial stage materials company that produces, distributes, markets and sells isotopes | Health Technology |
